Global Radiopharmaceutical Competitive Landscape Professional Research Report 2024

Global Radiopharmaceutical Competitive Landscape Professional Research Report 2024

Research Summary

A radiopharmaceutical is a medicinal compound that contains a radioactive isotope and is used in nuclear medicine for diagnostic or therapeutic purposes. These compounds are designed to target specific organs, tissues, or physiological processes within the body, allowing for the visualization or treatment of specific medical conditions. In diagnostic nuclear medicine procedures, radiopharmaceuticals emit gamma rays that can be detected using specialized imaging equipment, providing valuable information about the structure and function of organs or tissues. In therapeutic applications, the radioactive emissions from the radiopharmaceutical are used to deliver targeted radiation to diseased cells, such as in the treatment of certain types of cancer. Radiopharmaceuticals undergo rigorous testing and regulatory approval processes to ensure their safety and efficacy in medical applications.

According to DIResearch's in-depth investigation and research, the global Radiopharmaceutical market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Radiopharmaceutical include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare, China Isotope & Radiation, Jubilant Pharma, Eli Lilly, Advanced Accelerator Applications, SIEMENS, Dongcheng, Navidea etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Radiopharmaceutical. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Radiopharmaceutical market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Radiopharmaceutical market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Radiopharmaceutical industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Radiopharmaceutical Include:

Bracco Imaging

Bayer

Mallinckrodt

Nordion

Triad Isotopes

Lantheus

IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications

SIEMENS

Dongcheng

Navidea

Radiopharmaceutical Product Segment Include:

Actinium-225

Lutetium-177

Radium-223

Holmium-166

Other

Radiopharmaceutical Product Application Include:

Oncology

Cardiology

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Radiopharmaceutical Industry PESTEL Analysis

Chapter 3: Global Radiopharmaceutical Industry Porter’s Five Forces Analysis

Chapter 4: Global Radiopharmaceutical Major Regional Market Size and Forecast Analysis

Chapter 5: Global Radiopharmaceutical Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Radiopharmaceutical Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Radiopharmaceutical Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Radiopharmaceutical Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Radiopharmaceutical Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Radiopharmaceutical Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Radiopharmaceutical Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Radiopharmaceutical Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources